Sirio Pharma Hits Day High with Strong 5.18% Intraday Surge

Sirio Pharma Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable uptick in its stock performance today, gaining 5.18% as of March 27, 2026. The stock reached an intraday high of CNY 21.28, reflecting a significant movement in the market. In comparison to the broader market, represented by the China Shanghai Composite, which saw a modest increase of 0.63% today, Sirio Pharma's performance stands out. Over the past week, the stock has also outperformed the index, rising 4.28% while the composite declined by 1.09%. However, the stock's performance over the past month shows a decline of 5.73%, slightly better than the composite's drop of 5.99%. Despite these short-term gains, Sirio Pharma has faced challenges over the longer term, with a year-to-date decline of 19.84% and a five-year drop of 38.85%. The company's current market capitalization is CNY 5,559 million, with a price-to-earnings ratio of 24.00 and a dividend yield of 2.27%. These metrics highlight the company's position within a competitive industry landscape.